Ikarian Capital, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$272,093
-99.3%
32,547
-98.0%
0.03%
-99.5%
Q2 2023$41,040,648
+195331.7%
1,652,200
+71985.5%
6.54%
+217766.7%
Q1 2022$21,000
-99.4%
2,292
-98.9%
0.00%
-99.5%
Q4 2021$3,787,000
+15.4%
199,339
+102.2%
0.56%
+144.2%
Q3 2021$3,282,000
-15.4%
98,600
-1.4%
0.23%
-26.2%
Q2 2021$3,878,000
-19.5%
100,0000.0%0.31%
+93.2%
Q1 2021$4,820,000
-7.3%
100,0000.0%0.16%
-29.3%
Q4 2020$5,202,000
+48.2%
100,000
-68.4%
0.23%
-59.8%
Q4 2019$3,510,000316,2000.57%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders